Research Paper Advance Articles
Unveiling KLHL23 as a key immune regulator in hepatocellular carcinoma through integrated analysis
Figure 2. Somatic mutation and copy number variation characteristics of KLHL23. (A) CNV analysis of KLHL23 in 33 cancer types. (B) Mutation sites of KLHL23 as indicted through a cBioPortal analysis. (C) Genomic alterations of KLHL23. (D) TMB analysis of the indicated cancers. (E) MSI analysis of indicated cancers. (F) Survival analysis of the altered or unaltered genome of LIHC. (G) The altered genome of LIHC according to the cancer stage. (*P < 0.05, **P < 0.01, ***P < 0.001).